The multimodal antidepressant Lu AA21004: open-label long-term safety and tolerability study in major depressive disorder

被引：8
|
作者：
Florea, I. [1 ]
Dragheim, M. [1 ]
Loft, H. [2 ]
机构：
[1] H Lundbeck & Co AS, Mood & Anxiety Disorders, Copenhagen, Denmark
[2] H Lundbeck & Co AS, Biometr, Copenhagen, Denmark
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2012年 / 22卷
关键词：
D O I：
10.1016/S0924-977X(12)70383-8
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S255 / S256
页数：2
相关论文
共 50 条
  • [21] Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: An open-label study
    Wohlreich M.M.
    Mallinckrodt C.H.
    Watkin J.G.
    Hay D.P.
    BMC Geriatrics, 4 (1)
  • [22] AN OPEN-LABEL, MULTIPLE-DOSE STUDY IN HEALTHY ADULTS TO ASSESS THE DRUG INTERACTION POTENTIAL OF LU AA21004 USING THE INDIANA COCKTAIL
    Wang, Y.
    Wojtkowski, T.
    Hanson, E.
    Harris, S.
    Karim, A.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1114 - 1114
  • [23] A double-blind, randomised, placebo-controlled, relapse-prevention study with Lu AA21004 in patients with major depressive disorder
    Dragheim, M.
    Loft, H.
    Florea, I.
    Boulenger, J. P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S396 - S397
  • [24] Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
    Bang-Andersen, Benny
    Ruhland, Thomas
    Jorgensen, Morten
    Smith, Garrick
    Frederiksen, Kristen
    Jensen, Klaus Gjervig
    Zhong, Huailing
    Nielsen, Soren Moller
    Hogg, Sandra
    Mork, Arne
    Stensbol, Tine Bryan
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (09) : 3206 - 3221
  • [25] Long-term safety and efficacy, including anhedonia, of vortioxetine for major depressive disorder: findings from two open-label studies
    Mattingly, Gregory W.
    Necking, Oscar
    Schmidt, Simon Nitschky
    Reines, Elin
    Ren, Hongye
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (04) : 613 - 619
  • [26] Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
    Vieta, Eduard
    Earley, Willie R.
    Burgess, Maria V.
    Durgam, Suresh
    Chen, Changzheng
    Zhong, Yan
    Barabassy, Agota
    Nemeth, Gyorgy
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 76 - 83
  • [27] Εfficacy and safety of vortioxetine (Lu AA21004) in the treatment of adult patients with major depressive disorder: A systematic review and a meta-analysis of randomized controlled trials
    Gao, Shan
    Xie, Xingxing
    Fan, Ling
    Zhang, Deming
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (05)
  • [28] Tolerability and safety of topiramate in chinese patients with epilepsy - An open-label, long-term, prospective study
    Lu, Yang
    Wang, Xuefeng
    Li, Qihua
    Li, Jingmei
    Yan, Yong
    CLINICAL DRUG INVESTIGATION, 2007, 27 (10) : 683 - 690
  • [29] Tolerability and Safety of Topiramate in Chinese Patients with EpilepsyAn Open-Label, Long-Term, Prospective Study
    Yang Lu
    Xuefeng Wang
    Qihua Li
    Jingmei Li
    Yong Yan
    Clinical Drug Investigation, 2007, 27 : 683 - 690
  • [30] Lu AA21004, a novel multimodal antidepressant, produces regionally selective increases of multiple neurotransmitters-A rat microdialysis and electrophysiology study
    Pehrson, Alan L.
    Cremers, Thomas
    Betry, Cecile
    van der Hart, Marieke G. C.
    Jorgensen, Laerke
    Madsen, Mathias
    Haddjeri, Nasser
    Ebert, Bjarke
    Sanchez, Connie
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (02) : 133 - 145
12345